Genmab | GEN - Net Income


Genmab reported DKK31M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agios Pharmaceuticals USD -108.04M 4.61M Dec/2025
Almirall EUR 19.58M 7M Dec/2025
Amarin USD -1.22M 6.51M Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
argenx SE USD 532.95M 188.69M Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
BioMarin Pharmaceutical USD -46.57M 15.83M Dec/2025
Demant DKK 427M 690M Dec/2025
Exelixis USD 193.58M 8.73M Sep/2025
Fresenius Medical Care EUR 327M 52.2M Dec/2025
Galapagos EUR 782.15M 984.26M Dec/2025
Genmab DKK 31M 370M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GN Store Nord DKK 344M 271M Dec/2025
GRIFOLS EUR 98.25M 28.72M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Insmed USD -328.48M 41.54M Dec/2025
Lonza CHF 426M 119M Jun/2025
Merck EUR 319M 583M Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
UCB EUR 1.08B 608M Dec/2025